Utility of CAML as Diagnostic for Early Stage Lung Cancer

Clinical trial NCT03992183 · TERMINATED

Trial details

NCT number: NCT03992183
Sponsor: Fox Chase Cancer Center
Status: TERMINATED
Study type: OBSERVATIONAL

Pulmonary Nodule, Multiple Pulmonary Nodule, Solitary

Start date: 2019-05-21
Primary completion: 2022-11-14
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.